200 related articles for article (PubMed ID: 16143789)
21. A photon spectrometric dose-rate constant determination for the Advantage Pd-103 brachytherapy source.
Chen ZJ; Bongiorni P; Nath R
Med Phys; 2010 Feb; 37(2):672-4. PubMed ID: 20229876
[TBL] [Abstract][Full Text] [Related]
22. Dosimetric comparison between model 9011 and 6711 sources in prostate implants.
Zhang H; Beyer D
Med Dosim; 2013; 38(2):199-203. PubMed ID: 23510715
[TBL] [Abstract][Full Text] [Related]
23. The effect of seed anisotrophy on brachytherapy dose distributions using 125I and 103Pd.
Lindsay P; Battista J; Van Dyk J
Med Phys; 2001 Mar; 28(3):336-45. PubMed ID: 11318315
[TBL] [Abstract][Full Text] [Related]
24. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
[TBL] [Abstract][Full Text] [Related]
25. An approach to using conventional brachytherapy software for clinical treatment planning of complex, Monte Carlo-based brachytherapy dose distributions.
Rivard MJ; Melhus CS; Granero D; Perez-Calatayud J; Ballester F
Med Phys; 2009 Jun; 36(6):1968-75. PubMed ID: 19610285
[TBL] [Abstract][Full Text] [Related]
26. Dose verification with Monte Carlo technique for prostate brachytherapy implants with (125)I sources.
Zhang H; Baker C; McKinsey R; Meigooni A
Med Dosim; 2005; 30(2):85-91. PubMed ID: 15922174
[TBL] [Abstract][Full Text] [Related]
27. Quantifying the effect of seed orientation in postplanning dosimetry of low-dose-rate prostate brachytherapy.
Collins Fekete CA; Plamondon M; Martin AG; Vigneault É; Verhaegen F; Beaulieu L
Med Phys; 2014 Oct; 41(10):101704. PubMed ID: 25281943
[TBL] [Abstract][Full Text] [Related]
28. Dosimetric characteristics of the InterSource103 palladium brachytherapy source.
Meigooni AS; Sowards K; Soldano M
Med Phys; 2000 May; 27(5):1093-100. PubMed ID: 10841414
[TBL] [Abstract][Full Text] [Related]
29. Monte Carlo calculations and experimental measurements of dosimetry parameters of a new 103Pd source.
Li Z; Palta JR; Fan JJ
Med Phys; 2000 May; 27(5):1108-12. PubMed ID: 10841416
[TBL] [Abstract][Full Text] [Related]
30. Monte Carlo calculated TG-43 dosimetry parameters for the SeedLink 125Iodine brachytherapy system.
Medich DC; Munro JJ
Med Phys; 2003 Sep; 30(9):2503-8. PubMed ID: 14528972
[TBL] [Abstract][Full Text] [Related]
31. Influence of source batch S dispersion on dosimetry for prostate cancer treatment with permanent implants.
Nuñez-Cumplido E; Perez-Calatayud J; Casares-Magaz O; Hernandez-Armas J
Med Phys; 2015 Aug; 42(8):4933-40. PubMed ID: 26233219
[TBL] [Abstract][Full Text] [Related]
32. Prostate brachytherapy postimplant dosimetry: seed orientation and the impact of dosimetric anisotropy in stranded implants.
Chng N; Spadinger I; Rasoda R; Morris WJ; Salcudean S
Med Phys; 2012 Feb; 39(2):721-31. PubMed ID: 22320782
[TBL] [Abstract][Full Text] [Related]
33. Effect of edema, relative biological effectiveness, and dose heterogeneity on prostate brachytherapy.
Wang JZ; Mayr NA; Nag S; Montebello J; Gupta N; Samsami N; Kanellitsas C
Med Phys; 2006 Apr; 33(4):1025-32. PubMed ID: 16696479
[TBL] [Abstract][Full Text] [Related]
34. Isotope choice and the effect of edema on prostate brachytherapy dosimetry.
Butler WM; Merrick GS; Dorsey AT; Lief JH
Med Phys; 2000 May; 27(5):1067-75. PubMed ID: 10841411
[TBL] [Abstract][Full Text] [Related]
35. Dosimetric accuracy of a deterministic radiation transport based 192Ir brachytherapy treatment planning system. Part I: single sources and bounded homogeneous geometries.
Zourari K; Pantelis E; Moutsatsos A; Petrokokkinos L; Karaiskos P; Sakelliou L; Georgiou E; Papagiannis P
Med Phys; 2010 Feb; 37(2):649-61. PubMed ID: 20229874
[TBL] [Abstract][Full Text] [Related]
36. Experimental determination of the anisotropy function for the model 200 103Pd "light seed" and derivation of the anisotropy constant based upon the linear quadratic model.
Yue N; Nath R
Med Phys; 2002 Jun; 29(6):1120-9. PubMed ID: 12094982
[TBL] [Abstract][Full Text] [Related]
37. Feasibility of calibrating elongated brachytherapy sources using a well-type ionization chamber.
Meigooni AS; Awan SB; Dou K
Med Phys; 2006 Nov; 33(11):4184-9. PubMed ID: 17153397
[TBL] [Abstract][Full Text] [Related]
38. MCPI: a sub-minute Monte Carlo dose calculation engine for prostate implants.
Chibani O; Williamson JF
Med Phys; 2005 Dec; 32(12):3688-98. PubMed ID: 16475768
[TBL] [Abstract][Full Text] [Related]
39. Comparative study of permanent interstitial prostate brachytherapy post-implant evaluation among seven Italian institutes.
Mangili P; Stea L; Cattani F; Lappi S; Giglioli F; Calamia E; Ziglio F; Martinelli R; Longobardi B
Radiother Oncol; 2004 Apr; 71(1):13-21. PubMed ID: 15066291
[TBL] [Abstract][Full Text] [Related]
40. Monte Carlo dosimetric study of best industries and Alpha Omega Ir-192 brachytherapy seeds.
Ballester F; Granero D; Pérez-Calatayud J; Casal E; Puchades V
Med Phys; 2004 Dec; 31(12):3298-305. PubMed ID: 15651612
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
